Evidence map›Paper›PMID 41569476›Full record

ArticleMedical microbiology and immunology2026

A potent protein vaccines OmpW induces strong protective immunity against Klebsiella pneumoniae in a mouse model.

Ting Huang, Siyou Che, Hong Zhang, Wei Jiang, Danrui Hao, Zheng Lv, Yang Yuan, Yundong Zhang, Ruibin Yang, Linqiu Luo and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical microbiology and immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ting Huang *Antibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China. huangting@cdu.edu.cn.
Siyou Che *Antibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Hong Zhang *Department of Geriatrics, Traditional Chinese Medicine Hospital of Meishan, Meishan, China.
Wei JiangAntibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Danrui HaoAntibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Zheng LvAntibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Yang YuanKey Laboratory of Bio-Resources and Eco-Environment (Ministry of Education), College of Life Sciences, Sichuan University, Chengdu, China.
Yundong ZhangChengdu Medical College, Chengdu, China.
Ruibin YangAntibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Linqiu LuoAntibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Lufeng DanAntibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Yiwen ChuAntibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Kelei ZhaoAntibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University, Chengdu, China.
Yanan ShangInfectious Diseases Department, Traditional Chinese Medicine Hospital of Meishan, Meishan, China. shangyanan@cdutcm.edu.cn.

Funding

the high-level talent training program of Chengdu University 2081924014the National Natural Science Foundation of China 32270121the National Natural Science Foundation of China 32400477the Natural Science Foundation of Sichuan Province 2023NSFSC1231the Science and Technology Bureau Program of Chengdu Municipal Government 2016-XT00-00023-GX
6 · The paper itself

Abstract

Klebsiella pneumoniae causes severe respiratory-associated infections in healthy individuals, and widespread antibiotic resistance in K. pneumoniae poses a global health threat. Although great efforts have been taken to develop effective vaccines against K. pneumoniae, there are no licensed vaccines against K. pneumoniae available up to date. In the current study, we designed a potent subunit vaccine OmpW, which was obtained from an outer membrane protein (OmpW) to maximize host responses in mice. Antibody-mediated responses and protective effects were determined to compare the immunogenicity of the OmpW subunit vaccine in the vaccinated mice. Immunization experiments showed that mice immunized with recombinant OmpW generated high IgG antibody production, which promoted macrophage opsonophagocytic activity and induced strong serum bactericidal activity. The residual bacterial burdens from the different organs were declined in the immunized mice compared with the control group. Notably, immunization with the OmpW subunit vaccine provided better protection against K. pneumoniae challenge in vaccinated mice. The passive transfer of antiserum from OmpW-immunized mice also provided protection against K. pneumoniae infection. This study constitutes an important step toward developing potent antibacterial vaccines against K. pneumoniae infections and prevents further dissemination of K. pneumoniae strains.

Indexed as

Bacterial Outer Membrane ProteinsBacterial VaccinesKlebsiella InfectionsKlebsiella pneumoniaeAnimalsAntibodies, BacterialBacterial LoadDisease Models, AnimalFemaleImmunization, PassiveImmunoglobulin GMacrophagesMiceMice, Inbred BALB CPhagocytosisProtein Subunit VaccinesAntibodies, BacterialBacterial Outer Membrane ProteinsBacterial VaccinesImmunoglobulin GProtein Subunit VaccinesVaccines, SubunitAntibacterial immunityAntibody responsesKlebsiella pneumoniaeProtein vaccine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.